Terms: = Sarcomas AND RPN1, OST1, 6184, ENSG00000163902, P04843
6 results:
1. Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma.
Xu J; Guo K; Sheng X; Huang Y; Wang X; Dong J; Qin H; Wang C
Sci Rep; 2024 Mar; 14(1):7158. PubMed ID: 38531930
[TBL] [Abstract] [Full Text] [Related]
2. Quantitative signal intensity ratios to distinguish between subfascial lipoma and atypical lipomatous tumor/well-differentiated liposarcoma using short-tau inversion recovery (STIR) MRI.
Donners R; Krieg AH; Baumhoer D; Boll DT; Harder D
Diagn Interv Imaging; 2020 Jun; 101(6):383-390. PubMed ID: 32107197
[TBL] [Abstract] [Full Text] [Related]
3. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells.
Bui C; Ouzzine M; Talhaoui I; Sharp S; Prydz K; Coughtrie MW; Fournel-Gigleux S
FASEB J; 2010 Feb; 24(2):436-50. PubMed ID: 19812376
[TBL] [Abstract] [Full Text] [Related]
5. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
Fanburg-Smith JC; Bratthauer GL; Miettinen M
Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
[TBL] [Abstract] [Full Text] [Related]
6. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
Tsang KY; Fudenberg HH
Int J Immunopharmacol; 1981; 3(4):383-9. PubMed ID: 6174468
[TBL] [Abstract] [Full Text] [Related]
